Abstract
Polo-like kinase 4 (PLK4), a member of the polo-like kinase family, plays several important roles in mitotic regulation, including centrosome duplication, spindle formation, and cytokinesis. PLK4 overexpression is frequently detected in many human cancers, including ovarian cancer, and the inhibition of PLK4 activity results in cancer cell mitotic arrest and apoptosis. Therefore, PLK4 might be a valid therapeutic target for antitumor therapy. In the present study, we aimed to determine if YLZ-F5, a potent small-molecule inhibitor of PLK4, inhibits ovarian cancer cell growth. MTT assay showed that YLZ-F5 inhibited ovarian cancer cell proliferation in a concentration- and time-dependent manner. The results of colony formation assays were consistent with those of the MTT assay results. In addition, YLZ-F5 induced ovarian cancer cell apoptosis that was associated with activation of caspase-3/caspase-9. Moreover, YLZ-F5 caused aberrant in centriole duplication that was associated with the inhibition of PLK4 phosphorylation. Notably, we showed that YLZ-F5 promoted the accumulation of ovarian cancer cells with mitotic defects (> 4 N DNA content) in a concentration-dependent manner. Furthermore, YLZ-F5 markedly inhibited the migration ...Continue Reading
References
Feb 13, 2001·Cancer Letters·N TakaiI Miyakawa
Sep 28, 2002·Nature Structural Biology·Genie C LeungFrank Sicheri
Feb 19, 2004·British Journal of Cancer·W WeichertS Hauptmann
Jun 3, 2004·Nature Reviews. Molecular Cell Biology·Francis A BarrErich A Nigg
Jan 11, 2005·Oncogene·Noriyuki TakaiIsao Miyakawa
Oct 26, 2005·Nature Cell Biology·Robert HabedanckErich A Nigg
Nov 17, 2009·Cell·Erich A Nigg, Jordan W Raff
Jan 27, 2010·The Journal of Cell Biology·Andrew J HollandDon W Cleveland
Jul 31, 2010·Nature Reviews. Drug Discovery·Klaus Strebhardt
Oct 6, 2010·Cell Division·James E Sillibourne, Michel Bornens
Nov 26, 2010·Nature Reviews. Cancer·Susanne M A LensRené H Medema
Jun 10, 2011·Cell Cycle·Guillermo de CárcerMarcos Malumbres
Jul 2, 2011·Nature·UNKNOWN Cancer Genome Atlas Research Network
Jul 22, 2014·Cancer Cell·Jacqueline M MasonTak W Mak
Aug 15, 2014·Cancer Cell·Andrew J Holland, Don W Cleveland
Jan 27, 2015·Oncogene·V ArchambaultD Kachaner
Aug 6, 2015·Obstetrics and Gynecology·Rosemary D CressGary S Leiserowitz
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
Aug 26, 2016·Nature Reviews. Disease Primers·Ursula A MatulonisBeth Y Karlan
Nov 23, 2016·Cancer Research·Karineh KazazianCarol J Swallow
Jan 21, 2018·Cell Death & Disease·Xiangdong TianQiang Zhao
Feb 13, 2018·Proceedings of the National Academy of Sciences of the United States of America·Masanori KawakamiEthan Dmitrovsky
Oct 20, 2018·Cell Death & Disease·Qian LeiLuoting Yu
Oct 27, 2018·Molecular Medicine Reports·Yao HeQixiang Shao
Dec 21, 2018·International Journal of Oncology·Zhibin LiaoBixiang Zhang
Jan 9, 2019·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Mar 27, 2019·Lancet·Stephanie LheureuxAmit M Oza
May 18, 2019·Proceedings of the National Academy of Sciences of the United States of America·Michael F PressDennis J Slamon
Sep 8, 2019·Journal of Cancer Research and Clinical Oncology·Yi Zhao, Xin Wang